149 related articles for article (PubMed ID: 21308880)
21. Crohn's disease complicated by strictures: a systematic review.
Rieder F; Zimmermann EM; Remzi FH; Sandborn WJ
Gut; 2013 Jul; 62(7):1072-84. PubMed ID: 23626373
[TBL] [Abstract][Full Text] [Related]
22. Are inherited thrombotic risk factors associated with fibrostenosis in Crohn's disease?
Novacek G; Papay P; Miehsler W; Reinisch W; Lichtenberger C; Sunder-Plassmann R; Vogelsang H; Gratzer C; Mannhalter C
Inflamm Bowel Dis; 2011 Dec; 17(12):2505-11. PubMed ID: 21351205
[TBL] [Abstract][Full Text] [Related]
23. Fibrogenesis in Crohn's disease.
Burke JP; Mulsow JJ; O'Keane C; Docherty NG; Watson RW; O'Connell PR
Am J Gastroenterol; 2007 Feb; 102(2):439-48. PubMed ID: 17156147
[TBL] [Abstract][Full Text] [Related]
24. Smooth Muscle Hyperplasia/Hypertrophy is the Most Prominent Histological Change in Crohn's Fibrostenosing Bowel Strictures: A Semiquantitative Analysis by Using a Novel Histological Grading Scheme.
Chen W; Lu C; Hirota C; Iacucci M; Ghosh S; Gui X
J Crohns Colitis; 2017 Jan; 11(1):92-104. PubMed ID: 27364949
[TBL] [Abstract][Full Text] [Related]
25. Intestinal myofibroblast TRPC6 channel may contribute to stenotic fibrosis in Crohn's disease.
Kurahara LH; Sumiyoshi M; Aoyagi K; Hiraishi K; Nakajima K; Nakagawa M; Hu Y; Inoue R
Inflamm Bowel Dis; 2015 Mar; 21(3):496-506. PubMed ID: 25647156
[TBL] [Abstract][Full Text] [Related]
26. Results of the Fifth Scientific Workshop of the ECCO (II): Pathophysiology of Perianal Fistulizing Disease.
Siegmund B; Feakins RM; Barmias G; Ludvig JC; Teixeira FV; Rogler G; Scharl M
J Crohns Colitis; 2016 Apr; 10(4):377-86. PubMed ID: 26681764
[TBL] [Abstract][Full Text] [Related]
27. [Clinical predictive factors for Crohn's disease complications].
Cerqueira RM; Lago P
Acta Med Port; 2011 Dec; 24 Suppl 4():1057-62. PubMed ID: 22863518
[TBL] [Abstract][Full Text] [Related]
28. Assessment of stricturing Crohn's disease: Current clinical practice and future avenues.
Bettenworth D; Nowacki TM; Cordes F; Buerke B; Lenze F
World J Gastroenterol; 2016 Jan; 22(3):1008-16. PubMed ID: 26811643
[TBL] [Abstract][Full Text] [Related]
29. Clinical factors predictive of Crohn's disease complications and surgery.
Cerqueira RM; Lago PM
Eur J Gastroenterol Hepatol; 2013 Feb; 25(2):129-34. PubMed ID: 23104203
[TBL] [Abstract][Full Text] [Related]
30. Genetic factors conferring an increased susceptibility to develop Crohn's disease also influence disease phenotype: results from the IBDchip European Project.
Cleynen I; González JR; Figueroa C; Franke A; McGovern D; Bortlík M; Crusius BJ; Vecchi M; Artieda M; Szczypiorska M; Bethge J; Arteta D; Ayala E; Danese S; van Hogezand RA; Panés J; Peña SA; Lukas M; Jewell DP; Schreiber S; Vermeire S; Sans M
Gut; 2013 Nov; 62(11):1556-65. PubMed ID: 23263249
[TBL] [Abstract][Full Text] [Related]
31. Assessment of inflammatory and fibrotic stenoses in patients with Crohn's disease using contrast-enhanced ultrasound and computerized algorithm: a pilot study.
Schirin-Sokhan R; Winograd R; Tischendorf S; Wasmuth HE; Streetz K; Tacke F; Trautwein C; Tischendorf JJ
Digestion; 2011; 83(4):263-8. PubMed ID: 21273775
[TBL] [Abstract][Full Text] [Related]
32. Medical Therapy of Fibrostenotic Crohn's Disease.
Siegmund B
Viszeralmedizin; 2015 Aug; 31(4):259-64. PubMed ID: 26557834
[TBL] [Abstract][Full Text] [Related]
33. Intestinal fibrosis is associated with lack of response to Infliximab therapy in Crohn's disease.
de Bruyn JR; Becker MA; Steenkamer J; Wildenberg ME; Meijer SL; Buskens CJ; Bemelman WA; Löwenberg M; Ponsioen CY; van den Brink GR; D'Haens GR
PLoS One; 2018; 13(1):e0190999. PubMed ID: 29364909
[TBL] [Abstract][Full Text] [Related]
34. Crohn's disease associated strictures.
Chan WPW; Mourad F; Leong RW
J Gastroenterol Hepatol; 2018 May; 33(5):998-1008. PubMed ID: 29427364
[TBL] [Abstract][Full Text] [Related]
35. Genome-wide analysis of DNA methylation and gene expression defines molecular characteristics of Crohn's disease-associated fibrosis.
Sadler T; Bhasin JM; Xu Y; Barnholz-Sloan J; Chen Y; Ting AH; Stylianou E
Clin Epigenetics; 2016; 8():30. PubMed ID: 26973718
[TBL] [Abstract][Full Text] [Related]
36. Effectiveness of contrast-enhanced ultrasound for characterisation of intestinal inflammation in Crohn's disease: a comparison with surgical histopathology analysis.
Ripollés T; Rausell N; Paredes JM; Grau E; Martínez MJ; Vizuete J
J Crohns Colitis; 2013 Mar; 7(2):120-8. PubMed ID: 22483566
[TBL] [Abstract][Full Text] [Related]
37. Clinical predictors at diagnosis of disabling pediatric Crohn's disease.
Savoye G; Salleron J; Gower-Rousseau C; Dupas JL; Vernier-Massouille G; Fumery M; Merle V; Lerebours E; Cortot A; Turck D; Salomez JL; Lemann M; Colombel JF; Duhamel A
Inflamm Bowel Dis; 2012 Nov; 18(11):2072-8. PubMed ID: 22294515
[TBL] [Abstract][Full Text] [Related]
38. [Crohn's disease: a still tourbillon of etiopathogenetic theories and therapeutic strategies. Some implications in the field of urology].
Alberti C
G Chir; 2010 Mar; 31(3):124-33. PubMed ID: 20426926
[TBL] [Abstract][Full Text] [Related]
39. Endoscopic and medical management of fibrostenotic Crohn's disease.
Thienpont C; Van Assche G
Dig Dis; 2014; 32 Suppl 1():35-8. PubMed ID: 25531351
[TBL] [Abstract][Full Text] [Related]
40. Age of Diagnosis is Associated with Disease Presentation and Therapeutic Complications in Patients with Crohn's Disease.
Saad AM; Czul F; Sakuraba A; Rubin DT; Cohen RD
Inflamm Bowel Dis; 2016 May; 22(5):1027-31. PubMed ID: 26919459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
